CDEK
← All drugs Report issue

nadroparin

Small moleculeexperimental

Nadroparin is an anticoagulant belonging to a class of drugs called low molecular weight heparins (LMWHs). Nadroparin was developed by Sanofi-Synthélabo. — Wikipedia

Clinical trial activity

24 trials · 40 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
10
Phase 3
10
Phase 4
9

Earliest trial started Jun 1, 2002 (NCT00796692)

Timeline

2000s

  1. Jan 1, 2003

    Earliest Phase 3 Sponsor(trial)

  2. Jan 1, 2009

    Earliest Phase 2 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • fraxiparin
  • fraxiparine
  • nadroparin
  • nadroparin
  • nadroparin
  • nadroparin
  • nadroparin calcium
  • nadroparin calcium
  • nadroparin calcium
  • nadroparin calcium

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06319131N/AMay 1, 2024Fudan University, Huazhong University of Science and Technology, Jiao Tong University, Shanghai University of Traditional Chinese Medicine, Wuhan University
NCT04507178Phase 2Oct 1, 2021Free University of Amsterdam, University of Amsterdam
NCT04066764Phase 3Oct 1, 2019Anhui Medical University, Fudan University, Jiao Tong University, Qingdao University, Zhejiang University
NCT04067505Phase 3Sep 1, 2019Anhui Medical University, Fudan University, Jiao Tong University, Qingdao University, Zhejiang University
NCT02987946N/ADec 1, 2016Leiden University, Medtronic
NCT02957877Phase 4Mar 1, 2016The University of Hong Kong
NCT02630095Phase 4Dec 1, 2015Eastern Hepatobiliary Surgery Hospital, Fudan University, Jiao Tong University, Ningxia Medical University, Shanghai University of Traditional Chinese Medicine
NCT02526303N/AAug 13, 2015People's Liberation Army of China
NCT04982055Phase 4Apr 8, 2015Free University of Brussels
NCT02398357Phase 4Mar 1, 2015Fudan University
NCT01980849Phase 3Nov 1, 2013Air Force Military Medical University, China, People's Liberation Army of China
NCT01862978Phase 4May 1, 2013Jessenius Faculty of Medicine, University Hospital, Martin
NCT01828697Phase 4Apr 1, 2013Aspen Pharmaceuticals, Netherlands Organisation for Scientific Research, University of Amsterdam, University of Lyon
NCT02295150Phase 4Mar 1, 2013Rijnstate Hospital
NCT01431456Phase 3Oct 1, 2011University of Groningen
NCT01267305N/AJan 1, 2011Fudan University
NCT01019655Phase 3Jan 1, 2010University of Vienna
NCT00881088Phase 2/Phase 3 (Phase 3)Apr 1, 2009Red Cross Hospital Beverwijk
NCT00843492Phase 3Dec 1, 2008GlaxoSmithKline
NCT00421538Phase 3Jan 1, 2008Canadian Institutes of Health Research (CIHR), Government of France, McGill University, Swiss National Science Foundation, Technion University, University of Geneva, University of Montpellier, University of Ottawa
Showing 20 of 24 trials
Page 1 / 2

Organizations

Research & Development (40)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Fudan UniversityAcademic/Hospital6432011
Jiao Tong UniversityAcademic/Hospital4032015
Anhui Medical UniversityAcademic/Hospital2012019
GlaxoSmithKlineFor profit2212006
People's Liberation Army of ChinaGovernment2122013
Qingdao UniversityAcademic/Hospital2012019
Shanghai University of Traditional Chinese MedicineAcademic/Hospital2022015
University of AmsterdamAcademic/Hospital2222013
Zhejiang UniversityAcademic/Hospital2212019
Air Force Military Medical University, ChinaAcademic/Hospital1112013
Aspen PharmaceuticalsFor profit1012013
Canadian Institutes of Health Research (CIHR)Academic/Hospital1012008
Capital Medical UniversityAcademic/Hospital1112002
Eastern Hepatobiliary Surgery HospitalAcademic/Hospital1012015
Free University of AmsterdamAcademic/Hospital1012021
Free University of BrusselsAcademic/Hospital1112015
Government of FranceGovernment1012008
Huazhong University of Science and TechnologyAcademic/Hospital1012024
ItalfarmacoFor profit1112003
Jessenius Faculty of MedicineAcademic/Hospital1012013
40 organizations
Page 1 / 2